Paper · 29367285
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
Folgiero V and 17 others. EMBO Rep, 2018. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia. Papers, record 29367285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367285
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis Regulatory Proteins | Major topic |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Repressor Proteins | Major topic |
| Cell Line, Tumor | |
| Cell Proliferation | |
| DNA-Binding Proteins | |
| Gene Expression Regulation, Leukemic | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Neoplasm Recurrence, Local | |
| Promoter Regions, Genetic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,071,758 | The murine gene, Traube, is essential for the growth of preimplantation embryos. | Dev Biol | 2000 | https://conductscience.org/library/papers/11071758 | PubMed |
| 2 | 14,627,703 | AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14627703 | PubMed |
| 3 | 22,120,020 | A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis. | Exp Hematol | 2012 | https://conductscience.org/library/papers/22120020 | PubMed |
| 4 | 12,450,794 | Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12450794 | PubMed |
| 5 | 12,808,131 | A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12808131 | PubMed |
| 6 | 25,060,305 | C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance? | Leuk Res | 2014 | https://conductscience.org/library/papers/25060305 | PubMed |
| 7 | 23,021,215 | Transcriptional amplification in tumor cells with elevated c-Myc. | Cell | 2012 | https://conductscience.org/library/papers/23021215 | PubMed |
| 8 | 25,770,584 | Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy. | EMBO J | 2015 | https://conductscience.org/library/papers/25770584 | PubMed |
| 9 | 24,799,436 | deepTools: a flexible platform for exploring deep-sequencing data. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24799436 | PubMed |
| 10 | 21,602,269 | CENTDIST: discovery of co-associated factors by motif distribution. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21602269 | PubMed |
1 to 10 of 50
See all 50 referencesCited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,441,112 | Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42441112 | PubMed |
| 41,872,157 | AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41872157 | PubMed |
| 38,926,853 | Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/38926853 | PubMed |
| 37,767,562 | Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. | Haematologica | 2024 | https://conductscience.org/library/papers/37767562 | PubMed |
| 37,435,061 | AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. | Front Immunol | 2023 | https://conductscience.org/library/papers/37435061 | PubMed |
| 35,929,179 | AATF/Che-1 localizes to paraspeckles and suppresses R-loops accumulation and interferon activation in Multiple Myeloma. | EMBO J | 2022 | https://conductscience.org/library/papers/35929179 | PubMed |
| 34,785,906 | AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling. | Onco Targets Ther | 2021 | https://conductscience.org/library/papers/34785906 | PubMed |
| 34,266,450 | CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34266450 | PubMed |
| 33,737,337 | GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33737337 | PubMed |
| 33,186,461 | Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma. | Blood Adv | 2020 | https://conductscience.org/library/papers/33186461 | PubMed |
1 to 10 of 20
See all 20 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AATF | 26,574 | PubTator's text mining | https://conductscience.org/library/genes/26574 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29367285
GET https://conductscience.org/api/papers/v1/29367285/references?page=2